"St. Mary Medical Center is a leading provider of expert medical and urgent care to Northwest Indiana residents by investing in new technologies and innovative treatments. We are located off South Lake Park Avenue in Hobart Indiana. The hospital also utilizes multidisciplinary teams of health professionals and shared governance among the nursing staff for increased collaboration ad accountability in patient care. These efforts have led to the achievement of numerous quality awards and accreditation, recognizing St. Mary Medical Center's excellence in health outcomes and patient experience. Since 1973, St. Mary Medical Center has met the healthcare needs of the Northwest Indiana community. Let us help you, every step of the way."

During the past decade, Saint Mary Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Mary Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Mary Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "BTG International Inc." with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Saint Mary Medical Center" are "Endometrial Serous Adenocarcinoma" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials) and "ALK Positive" (1 trials). Many other conditions were trialed in "Saint Mary Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Mary Medical Center" are "Drug" (14 trials), "Other" (11 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Paclitaxel" (6 trials), "Computed Tomography" (5 trials), "Questionnaire Administration" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Saint Mary Medical Center" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Mary Medical Center". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Saint Mary Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saint Mary Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".